ACS Combinatorial Science p. 444 - 455 (2016)
Update date:2022-08-04
Topics:
Myers, Stephanie M.
Bawn, Ruth H.
Bisset, Louise C.
Blackburn, Timothy J.
Cottyn, Betty
Molyneux, Lauren
Wong, Ai-Ching
Cano, Celine
Clegg, William
Harrington, Ross. W.
Leung, Hing
Rigoreau, Laurent
Vidot, Sandrine
Golding, Bernard T.
Griffin, Roger J.
Hammonds, Tim
Newell, David R.
Hardcastle, Ian R.
The extracellular-related kinase 5 (ERK5) is a promising target for cancer therapy. A high-throughput screen was developed for ERK5, based on the IMAP FP progressive binding system, and used to identify hits from a library of 57-617 compounds. Four distinct chemical series were evident within the screening hits. Resynthesis and reassay of the hits demonstrated that one series did not return active compounds, whereas three series returned active hits. Structure-activity studies demonstrated that the 4-benzoylpyrrole-2-carboxamide pharmacophore had excellent potential for further development. The minimum kinase binding pharmacophore was identified, and key examples demonstrated good selectivity for ERK5 over p38α kinase.
View MoreHubei Xinghuo Chemical Co., Ltd.,
Contact:13925817279 13907299441
Address:Xinghuo Fine Chemistry Industrial Park, Xiaochang County, Hubei Province, China
Shanghai Egoal Chemical Co.,Ltd
Contact:+86-21-50333091
Address:Yangming Garden Square 3,YangGao North Road 1188, Pudong New District, Shanghai
Xinchang Jiu Xin Pharmaceutical Co., Ltd
website:http://www.jiuxinpharm.com
Contact:86 137 5756 8585
Address:Poyang industry Park
Contact:+86-10-59484199
Address:No.58-A1026 Liangguan Street
Kaiping Genuine Biochemical Pharmaceutical Co.,Ltd.
Contact:+86-750-2881198
Address:No.1, Xinke Road, Shatang Town, Kaiping, Guangdong Province, P.R.China
Doi:10.1111/j.2042-7158.1979.tb13528.x
(1979)Doi:10.1039/P19810000947
(1981)Doi:10.1016/j.tetlet.2006.07.156
(2006)Doi:10.1021/jm00324a019
(1966)Doi:10.1002/anie.201802563
(2018)Doi:10.1039/jr9460000729
(1946)